Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization
Paolo Milani, Amedeo Massacesi, Stefano Ciaccia, Marco Setaccioli, Stefania Moschini, Fulvio BergaminiDipartimento di Oculistica, Istituto Auxologico Italiano, Milano, ItalyBackground: The aim of this study was to evaluate the efficacy of intravitreal bevacizumab when administered on an as-needed ba...
Guardado en:
Autores principales: | Bergamini F, Moschini S, Setaccioli M, Ciaccia S, Massacesi A, Milani P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8853ba05e850495e89b7caf57fc51a6f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
por: Milani P, et al.
Publicado: (2016) -
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Jia-Kang Wang, et al.
Publicado: (2018) -
Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Shatriah I, et al.
Publicado: (2011) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis D, et al.
Publicado: (2017) -
Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala NV, et al.
Publicado: (2014)